NCT06488417View on ClinicalTrials.gov

Frankincense Supplements and Inflammation

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

August 12, 2024

Study Completion Date

August 21, 2024

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Frankincense essential oil + boswellic acid supplement

This supplement contains frankincense essential oil and boswellic acid as its active ingredients.

DIETARY_SUPPLEMENT

Frankincense essential oil supplement

This supplement contains frankincense essential oil as its active ingredient.

Trial Locations (1)

84062

doTERRA International, Pleasant Grove

All Listed Sponsors
lead

dōTERRA International

INDUSTRY

NCT06488417 - Frankincense Supplements and Inflammation | Biotech Hunter | Biotech Hunter